Deutsche Bank AG Raises Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Deutsche Bank AG grew its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 45.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,462 shares of the medical instruments supplier's stock after purchasing an additional 5,747 shares during the period. Deutsche Bank AG owned about 0.08% of LeMaitre Vascular worth $1,701,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. New York State Teachers Retirement System grew its holdings in shares of LeMaitre Vascular by 1.2% during the fourth quarter. New York State Teachers Retirement System now owns 8,189 shares of the medical instruments supplier's stock worth $755,000 after purchasing an additional 100 shares during the last quarter. Flputnam Investment Management Co. grew its holdings in LeMaitre Vascular by 3.6% during the 4th quarter. Flputnam Investment Management Co. now owns 2,923 shares of the medical instruments supplier's stock worth $269,000 after acquiring an additional 102 shares during the last quarter. Norden Group LLC increased its position in LeMaitre Vascular by 4.5% in the 4th quarter. Norden Group LLC now owns 2,371 shares of the medical instruments supplier's stock valued at $218,000 after acquiring an additional 103 shares during the period. Blue Barn Wealth LLC raised its stake in shares of LeMaitre Vascular by 4.4% during the fourth quarter. Blue Barn Wealth LLC now owns 2,485 shares of the medical instruments supplier's stock valued at $229,000 after acquiring an additional 104 shares during the last quarter. Finally, Shaker Investments LLC OH lifted its holdings in shares of LeMaitre Vascular by 0.8% during the fourth quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier's stock worth $1,285,000 after purchasing an additional 112 shares during the period. Institutional investors and hedge funds own 84.64% of the company's stock.

LeMaitre Vascular Stock Up 0.1%

NASDAQ:LMAT traded up $0.06 during midday trading on Thursday, hitting $81.07. The company had a trading volume of 219,640 shares, compared to its average volume of 168,175. The company has a market capitalization of $1.83 billion, a PE ratio of 44.30, a P/E/G ratio of 2.22 and a beta of 0.86. LeMaitre Vascular, Inc. has a 52-week low of $71.42 and a 52-week high of $109.58. The stock's fifty day moving average price is $84.02 and its 200-day moving average price is $92.11.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). The business had revenue of $59.87 million during the quarter, compared to the consensus estimate of $57.61 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The company's revenue was up 12.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.44 earnings per share. As a group, research analysts forecast that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.

LeMaitre Vascular Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date of this dividend is Thursday, May 15th. LeMaitre Vascular's payout ratio is 40.40%.

Insider Buying and Selling at LeMaitre Vascular

In related news, CEO George W. Lemaitre sold 4,399 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $85.10, for a total value of $374,354.90. Following the completion of the transaction, the chief executive officer now directly owns 1,827,003 shares in the company, valued at $155,477,955.30. This trade represents a 0.24% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Trent G. Kamke sold 2,009 shares of the business's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $82.12, for a total transaction of $164,979.08. Following the sale, the insider now directly owns 5,564 shares in the company, valued at $456,915.68. The trade was a 26.53% decrease in their position. The disclosure for this sale can be found here. Insiders sold 102,009 shares of company stock valued at $8,721,836 in the last 90 days. Insiders own 9.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on LMAT shares. Barrington Research downgraded LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Lake Street Capital raised their price objective on LeMaitre Vascular from $105.00 to $110.00 and gave the company a "buy" rating in a research note on Friday, February 28th. Oppenheimer downgraded LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Finally, Wells Fargo & Company began coverage on shares of LeMaitre Vascular in a report on Thursday, February 13th. They set an "equal weight" rating and a $95.00 price objective for the company. Five research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $98.14.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.